A simple device can improve the ability of patients with arm disability to play physiotherapy-like computer games, according to new research.
The low-cost invention, called gripAble™, consists of a lightweight electronic handgrip, which interacts wirelessly with a standard PC tablet to enable the user to play arm-training games. To use it, patients squeeze, turn or lift the handgrip, and it vibrates in response to their performance whilst playing. The device uses a novel mechanism, which can detect the tiny flicker movements of severely paralysed patients and channel them into controlling a computer game.
Special-training computer games, controlled by the device, have been designed for people with no previous experience of using computers. For example one computer game requires the user to squeeze repeatedly to slowly reveal a photograph.
In a new study published in PLOS ONE, researchers from Imperial College London have shown that using the device increased the proportion of paralysed stroke patients able to direct movements on a tablet screen by 50 per cent compared to standard methods. In addition, the device enabled more than half of the severely disabled patients in the study to engage with arm-training software, whereas none of the patients were able to use conventional control methods such as swiping and tapping on tablets and smartphones.
Over five million people in the UK live with arm weakness - approximately one million of them following a stroke, plus others who have neurological and musculoskeletal conditions. Arm weakness contributes to physical disability that requires expensive long-term care. For example, treatment for stroke costs the NHS £9 billion a year, which is five per cent of the total NHS budget. The only intervention shown to improve arm function is repetitive, task-specific exercise but this is limited by the cost and availability of physiotherapists.
The gripAble™ device is designed for patients to use unsupervised in hospital and at home. The research tested the gripAble™ device with stroke patients who had suffered successive strokes with arm paralysis at Imperial College Healthcare NHS Trust over six months. The researchers assessed their ability to use gripAble™ to control mobile gaming devices such as tablets that could be used for rehabilitation and compared this to their use of conventional methods such as swiping and tapping.
They found that 93 per cent of patients were able to make meaningful movements to direct the cursor as a result of using gripAble™. In contrast, 67 per cent of patients were able to use mobile gaming devices by swiping on a tablet. For other types of control over the tablet, such as tapping or using joysticks, the number of patients able to make meaningful movements was lower.
The success of the device was most apparent for patients with severe arm weakness: no patients in this group were able to use conventional controls to play training games, whereas 58% could use gripAble™.
In a smaller sub-group the trial also demonstrated that severely disabled patients could play computer games that involve tracking a target with almost as good accuracy as healthy people.
The clinical trial was carried out at Charing Cross Hospital, part of Imperial College Healthcare Trust, between 2014 and 2015. The team is now carrying out a feasibility study in North West London to test the use of the device in patients' homes.
The potential of gripAble™ as a means of delivering cost-effective physiotherapy was recognised by a NHS England Innovation Challenge Prize in early 2016.
Lead researcher Dr Paul Bentley, who is a Clinical Senior Lecturer at Imperial College London and Honorary Consultant Neurologist at Imperial College Healthcare NHS Trust , said: "In the UK 100,000 new cases of arm weaknesses are diagnosed each year following a stroke. Often this impairs people's ability to carry out daily activities, requiring long-term care. The use of mobile-gaming could provide a cost-effective and easily available means to improve the arm movements of stroke patients but in order to be effective patients of all levels of disability should be able to access it.
"We have developed the gripAble™ device to improve arm and cognitive function of patients who have mild to severe arm weaknesses. Unlike other therapies currently on the NHS, gripAble™ is a low cost device which can be used in hospitals and independently by patients at home. As such it could potentially help save the health service millions of pounds. We now intend to further develop the device so we can help more patients who are currently suffering from the effects of poor arm and upper body mobility."
The researchers collaborated with Human Robotics Group at Imperial College London to develop the device. The research is funded by the Imperial Confidence in Concept Award, the NHS England Innovation Challenge Prize, and the EU 7th Framework Programme for Research and Technological Development grants.
The gripAble™ device is an example of the work of the Imperial Academic Health Science Centre (AHSC). This is a partnership between Imperial College London and three NHS Trusts, which aims to improve patient outcomes by harnessing scientific discoveries and translating them as quickly as possible into new diagnostics, devices and therapies, in the NHS and beyond. The researchers are working with Imperial Innovations, the College's technology transfer partner, to spinout gripAble™ as a digital healthcare start-up to commercialise the device.
To find out more about plans for the company and the current gripAble™ clinical trial please contact Dr Paul Rinne on firstname.lastname@example.org.
For more information, please contact:
AHSC Communications Officer
Imperial College AHSC
Tel: +44 (0)20 7594 6708 / =44 (0) 7976 918968
Out of hours duty media officer: +44 (0)7803 886 248
Notes to editors
1. Journalists can watch a video on the gripAble™ device on this link https://www.youtube.com/watch?v=Snt-BqIOJO0
2. Photographs of the gripAble™ device can be downloaded from https://icseclzt.cc.ic.ac.uk/pickup.php?claimID=9fqwUEUYPQogQjqD&claimPasscode=dPHCQEicxSQeX6Gy&emailAddr=f.davenport%40imperial.ac.uk
Claim ID: 9fqwUEUYPQogQjqD Claim Passcode: dPHCQEicxSQeX6Gy
3. Reference for the paper is : Rinne P, Mace M, Nakornchai T, Zimmerman K, Fayer S, Sharma P, et al. (2016) Democratizing neurorehabilitation: how accessible are low-cost mobile-gaming technologies for self-rehabilitation of arm disability in stroke? PLoS ONE 11(10): e0163413. doi:10.1371/journal.pone.0163413
Journalists can access the research paper before the embargo lifts on this link https://fileexchange.imperial.ac.uk/pickup.php?claimID=Ybx5DEisYZ8GhJV7&claimPasscode=RUAVJQCw65momZFX&emailAddr=f.davenport%40imperial.ac.uk
Claim ID: Ybx5DEisYZ8GhJV7 Claim Passcode: RUAVJQCw65momZFX
4. gripAble™ won an NHS England Innovation Challenge Prize and UK Stroke Association Prize in 2015-16. It came runners-up in the global OneStart 2016 healthcare accelerator programme (out of 750 healthcare start ups), and is listed as one of the 'Must-See Digital Health Startups of 2016' by the US Health 2.0 movement. For more information see http://www.gribAble.co
5. About Imperial College Academic Health Science Centre
Imperial College Academic Health Science Centre (AHSC) is a partnership between Imperial College London, Imperial College Healthcare NHS Trust, Royal Brompton & Harefield NHS Foundation Trust and the Royal Marsden NHS Foundation Trust, based in West London.
Established in 2007, it was the first AHSC to be created in the UK and was formally designated by the Department of Health in 2009.
The partnership brings together multi-disciplinary research and education from across all faculties at the College with the resources and critical mass of the three Trusts to advance discovery and innovation within healthcare.
The purpose of Imperial College AHSC is to utilise excellence in research and education to transform health outcomes, and support the UK's globally competitive position in healthcare related industries by increasing societal and economic gain.
The AHSC is nested within Imperial College Health Partners, the Academic Health Science Network for North West London, which will ensure that discoveries and innovations are applied on a national and global scale.
6. About Imperial College London:
Imperial College London is one of the world's leading universities. The College's 16,000 students and 8,000 staff are expanding the frontiers of knowledge in science, medicine, engineering and business, and translating their discoveries into benefits for society.
Founded in 1907, Imperial builds on a distinguished past - having pioneered penicillin, holography and fibre optics - to shape the future. Imperial researchers work across disciplines to improve health and wellbeing, understand the natural world, engineer novel solutions and lead the data revolution. This blend of academic excellence and its real-world application feeds into Imperial's exceptional learning environment, where students participate in research to push the limits of their degrees.
Imperial collaborates widely to achieve greater impact. It works with the NHS to improve healthcare in west London, is a leading partner in research and education within the European Union, and is the UK's number one research collaborator with China.
Imperial has nine London campuses, including its White City Campus: a research and innovation centre that is in its initial stages of development in west London. At White City, researchers, businesses and higher education partners will co-locate to create value from ideas on a global scale. http://www.imperial.ac.uk